MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.jhep.2022.11.028

Медицинская библиотека · Journal of hepatology · 2022

NAFLD and NASH biomarker qualification in the LITMUS consortium - Lessons learned.

Rasmussen Daniel Guldager Kring, Anstee Quentin M, Torstenson Richard, Golding Bruno, Patterson Scott D, Brass Clifford, Thakker Paresh, Harrison Stephen, Billin Andrew N, Schuppan Detlef, Dufour Jean-François, Andersson Anneli, Wigley Ioan, Shumbayawonda Elizabeth, Dennis Andrea, Schoelch Corinna, Ratziu Vlad, Yunis Carla, Bossuyt Patrick, Karsdal Morten Asser

СтатьяОбзорПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

Biomarkers have the potential to accelerate drug development, as early indicators of improved clinical response, to improve patient safety, and for personalised medicine. However, few have been approved through the biomarker qualification pathways of the regulatory agencies. This paper outlines how biomarkers can accelerate drug development, and reviews the lessons learned by the EU IMI2-funded LITMUS consortium, which has had several interactions with regulatory agencies in both the US and EU regarding biomarker qualification in patients with non-alcoholic fatty liver disease and non-alcoholic steatohepatitis. Sharing knowledge of such interactions with the scientific community is of paramount importance to increase the chances of qualification of relevant biomarkers that may accelerate drug development, and thereby help patients, across disease indications. A qualified biomarker enables a decision to be made that all understand and support in a common framework.

Для цитирования: Rasmussen Daniel Guldager Kring, Anstee Quentin M, Torstenson Richard, Golding Bruno, Patterson Scott D, Brass Clifford, Thakker Paresh, Harrison Stephen, Billin Andrew N, Schuppan Detlef, Dufour Jean-François, Andersson Anneli, Wigley Ioan, Shumbayawonda Elizabeth, Dennis Andrea, Schoelch Corinna, Ratziu Vlad, Yunis Carla, Bossuyt Patrick, Karsdal Morten Asser. NAFLD and NASH biomarker qualification in the LITMUS consortium - Lessons learned.. Journal of hepatology. 2022. DOI: 10.1016/j.jhep.2022.11.028.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.